A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)

SARS-CoV-2 directly targets alveolar epithelial cells and can lead to surfactant deficiency. Early reports suggested surfactant replacement may be effective in improving outcomes. The aim of the study to assess the feasibility and efficacy of nebulized surfactant in mechanically ventilated COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Dushianthan, Ahilanandan, Clark, Howard W., Brealey, David, Pratt, Danny, Fink, James B., Madsen, Jens, Moyses, Helen, Matthews, Lewis, Hussell, Tracy, Djukanovic, Ratko, Feelisch, Martin, Postle, Anthony D., Grocott, Michael P. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684757/
https://www.ncbi.nlm.nih.gov/pubmed/38017061
http://dx.doi.org/10.1038/s41598-023-47672-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684757/
https://www.ncbi.nlm.nih.gov/pubmed/38017061
http://dx.doi.org/10.1038/s41598-023-47672-x

Ejemplares similares